scispace - formally typeset
D

Daisuke Morisawa

Researcher at Hyogo College of Medicine

Publications -  30
Citations -  348

Daisuke Morisawa is an academic researcher from Hyogo College of Medicine. The author has contributed to research in topics: Heart failure & Diastole. The author has an hindex of 10, co-authored 30 publications receiving 269 citations. Previous affiliations of Daisuke Morisawa include Edwards Lifesciences Corporation & University of California, Irvine.

Papers
More filters
Journal ArticleDOI

Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

TL;DR: Increased diastolic filling pressure is associated with a higher rate of LAA thrombus in AF, partly through blood stasis or impaired LAA function, and increased quartile of E/e' was negatively associated with LAA flow velocity and positively with rate of SEC.
Journal ArticleDOI

Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease.

TL;DR: Renal iron accumulation seems to be associated with renal interstitial fibrosis in a rat model of CKD, and increased renal gene expression of CD68, tumor necrosis factor-α and monocyte chemoattractant protein-1 was suppressed in CKD rats with iron chelation.
Journal ArticleDOI

Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.

TL;DR: Salt supplementation rather than salt restriction evoked favorable diuresis through increasing GFR in patients with ADHF, and the findings support an efficacious novel approach of the treatment of ADHF.
Journal ArticleDOI

Diagnostic and prognostic significance of cardiovascular vortex formation.

TL;DR: Diagnostic and prognostic significance of vortices and vortex imaging in the heart, their applications in clinical medicine, and how these flow features can be used to assess functional status of the heart are summarized.
Journal ArticleDOI

Comparison of the Effects of Telmisartan and Olmesartan on Home Blood Pressure, Glucose, and Lipid Profiles in Patients with Hypertension, Chronic Heart Failure, and Metabolic Syndrome

TL;DR: In this paper, the effects of telmisartan and olmesartan in 20 patients with chronic heart failure and metabolic syndrome were compared, and the authors concluded that telisartan was more beneficial than olmes-artan for controlling blood pressure in the early morning, as well as for improving glucose and lipid profiles in patients with hypertension, chronic congestive heart failure, and metabolic disorders.